MARKET

DXCM

DXCM

DexCom
NASDAQ

Real-time Quotes | Nasdaq Last Sale

407.35
+7.14
+1.78%
After Hours: 408.00 +0.65 +0.16% 19:48 07/02 EDT
OPEN
402.22
PREV CLOSE
400.21
HIGH
415.48
LOW
398.06
VOLUME
1.08M
TURNOVER
--
52 WEEK HIGH
428.59
52 WEEK LOW
138.28
MARKET CAP
38.41B
P/E (TTM)
255.81
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DXCM stock price target is 399.29 with a high estimate of 500.00 and a low estimate of 266.00.

EPS

DXCM News

More
Dow Jones' Strength Wavers Due To Recent Rise In Coronavirus Cases; Growth Stocks Lead Market
The Dow Jones traded near break-even as the S&P; 500 and Nasdaq gained strength in heavy volume. A handful of Leaderboard stocks also traded in buy zones.
Investor's Business Daily · 2d ago
Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report?
DexCom (DXCM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks · 2d ago
If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now
Motley Fool · 2d ago
These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020
marketwatch.com · 2d ago
DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know
Zacks · 3d ago
Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time
Business Wire · 3d ago
DexCom to redeem convertible debt due 2022
Seeking Alpha - Article · 3d ago
Don't Buy Falling Financials, Buy These Stocks Instead
Seeking Alpha - Article · 06/27 01:32

Industry

Medical Equipment, Supplies & Distribution
+0.80%
Healthcare Equipment & Supplies
+0.92%

Hot Stocks

Symbol
Price
%Change

About DXCM

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes and for use by healthcare providers. The Company's products consist of DexCom G4 PLATINUM and DexCom G5 Mobile. The Company is commercializing its fifth generation CGM system. The Company's markets DexCom G4 PLATINUM under a Conformite Europeenne Marking (CE Mark), in the European Union, Australia, New Zealand and the countries in Asia and Latin America, and in the United States with approval from the United States Food and Drug Administration (FDA). The DexCom G4 PLATINUM with Share remote monitoring system uses a wireless connection between a patient's receiver and an application on the patient's iPhone, iPod touch, or iPad to transmit glucose information to applications on the mobile devices of designated recipients (followers).
More

Webull offers kinds of DexCom, Inc. stock information, including NASDAQ:DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.